Hughes Steven George sold RNA
September 22, 2025 · Form 4 insider transaction
Hughes Steven George sold 2,208 shares of Atrium Therapeutics, Inc. at $40.58 per share, a transaction worth $89.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,208
Price
$40.58
Total value
$89.6K
InsiderHughes Steven George
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 22, 2025
Filing dateSeptember 23, 2025
Shares owned after38,867
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 12, 2024.